Abstract
Fourteen cases of intracranial meningioma were characterized after chloroform/methanol extraction by31P nuclear magnetic resonance (NMR) spectroscopy at 202.4 MHz. Each phospholipid class detected in the extracts was identified and quantitated in terms of its molar percentage relative to the total phospholipids measured. The following phospholipids were assayed by31P NMR: phosphatidylglycerol, phosphatidic acid, diphosphatidylglycerol, ethanolamine plasmalogen, phosphatidylethanolamine (PE), lysophosphatidylinositol, phosphatidylserine, sphingomyelin, lysophosphatidylcholine (LPC), phosphatidylinositol (PI), sphingosylphosphorylcholine and phosphatidylcholine. In addition, two unidentified phospholipids were detected with resonances at 0.13 and −0.78 ppm, respectively. Three distinct types of spectra were obtained on the extracts and grouped accordingly for comparison purposes. Type 1 tumors showed unusual31P NMR profiles with low levels of PE and PI and elevated levels of LPC; type 2 tumors were characterized by low levels of the ethanolamine phospholipids and near equivalent levels of PI and LPC. The spectra of type 1 and type 2 tumors were characteristic of degenerative cells that lacked membrane permeability associated with loss of ethanolamine plasmalogen in the presence of significant phospholipid turnover. Meningiomas belonging to the third spectral type showed characteristics similar to those of normal tissues with normal levels of PE and ethanolamine plasmalogen, as well as very low levels of LPC relative to PI. Type 3 tumors lacked the characteristic signs of degeneration noted in type 1 and type 2 tumors. The data corroborate and augmentin vivo spectroscopic findings reported earlier and demonstrate the value of31P NMR spectroscopic phospholipid analysis on lipid extracts for the characterization of meningiomas.
Similar content being viewed by others
Abbreviations
- ATP:
-
adenosine triphosphate
- CPLAS:
-
choline plasmalogen
- CPLIP:
-
choline phospholipid
- DPG:
-
diphosphatidylglycerol, cardiolipin
- EDTA:
-
(ethylenedinitrilo)tetraacetic acid
- EPLAS:
-
ethanolamine plasmalogen
- LPC:
-
lysophosphatidylcholine
- LPI:
-
lysophosphatidylinositol
- NMR:
-
nuclear magnetic resonance
- PA:
-
phosphatidic acid
- PC:
-
phosphatidylcholine
- PE:
-
phosphatidylethanolamine
- PG:
-
phosphatidylglycerol
- PI:
-
phosphatidylinositol
- PS:
-
phosphatidylserine
- SM:
-
sphingomyelin
- SPC:
-
sphingosylphosphorylcholine
- U:
-
unidentified phospholipid
References
Peeling, J., and Sutherland, G. (1992)Magn. Reson. Med. 24, 123–136.
Gill, S.S., Thomas, D.G., Van Bruggen, N., Gadian, D.G., Peden, C.J., Bell, J.D., Cox, I.J., Menon, D.K., Iles, R.A., Bryant, D., and Coutts, G.A. (1990)J. Comput. Assist. Tomogr. 14, 497–504.
Cadoux-Hudson, T.A., Blackledge, M.J., Rajagopalan, B., Taylor, D.J., and Radda, G.K. (1989)Br. J. Cancer. 60, 430–436.
Henriksen, O., Wieslander, S., Gjerris, F., and Jensen, K.M. (1991)Acta Radiol. 32, 95–99.
Bruhn, H., Frahm, J., Gyngell, M.L., Merboldt, K.D., Hanicke, W., Sauter, R., and Hamburger, C. (1989)Radiology 172, 541–548.
Thomsen, C., Jensen, K.E., Achten, E., and Henriksen, O. (1988)Acta Radiol. 29, 77–82.
Heindel, W., Bunke, J., Glathe, S., Steinbrich, W., and Mollevanger, L. (1988)J. Comput. Assist. Tomogr. 12, 907–916.
Oberhaensli, R.D., Hilton-Jones, D., Bore, P.J., Hands, L.J., Rampling, R.P., and Radda, G.K. (1986)Lancet 2, 8–11.
Hubesch, B., Sappey-Marinier, D., Roth, K., Meyerhoff, D.J., Matson, G.B., and Wiener, M.W. (1990)Radiology 174, 401–409.
Just, M., and Thelen, M. (1988)Radiology 169, 779–785.
Daly, P.F., and Cohen, J.S. (1989)Cancer Res. 49, 770–779.
Heindel, W., Heiss, W.D., Bunke, J., Herholz, K., Glathe, S., and Jeske, J. (1988)Proc. Soc. Magn. Res. Med. 2, 717.
Arnold, D.L., Shoubridge, E.A., Feindel, W., and Villemure, J.G. (1987)Can. J. Neurol. Sci. 14, 570–575.
Heindel, W., Bunke, J., Steinbrich, W., and Friedmann, G. (1987)Proc. Soc. Magn. Res. Med. 1, 153.
Tanaka, C., Naruse, S., Horikawa, Y., and Higuchi, T. (1988)Proc. Soc. Magn. Res. Med. 1, 318.
Shoubridge, E.A., Arnold, D.L., Emrich, J.F., Villemure, J.G., and Feindel, W. (1988)Proc. Soc. Magn. Res. Med. 2, 616.
Redmond, O., Stack, J. Scully, M., Dervan, P., Carney, D., and Ennis, J.T. (1988)Symposium on Positron Emission Tomography, p. 16.
Pettegrew, J.W., Moossy, J., Withers, G., McKeag, D., and Panchalingam, K. (1988)J. Neuropathol. Exp. Neurol. 47, 235–248.
Pettegrew, J.W., Withers, G., and Panchalingam, K. (1990) inNMR: Principles and Applications to Biomedical Research (Pettegrew, J.W., ed.) pp. 204–254, Springer-Verlag, New York.
Klunk, W.E., McClure, R.J., and Pettegrew, J.W. (1991)J. Neurochem. 56, 1997–2003.
Bradler, J.E., Barrionuevo, G., Panchalingam, K., McKeag, D., and Pettegrew, J.W. (1991)Synapse 9, 7–13.
Meneses, P., Para, P.F., and Glonek, T. (1989)J. Lipid Res. 30, 458–461.
Folch, J., Lees, M., and Sloane-Stanley, G.H. (1957)J. Biol. Chem. 226, 497–509.
Meneses, P., Navarro, J.N., and Glonek, T. (1993)Int. J. Biochem. 25, 903–910.
Meneses, P., and Glonek, T. (1988)J. Lipid Res. 29, 679–689.
Glonek, T. (1994) inPhosphorus-31 NMR Spectral Properties in Compound Characterization and Structural Analysis (Quin, L.D., and Verkade, J.G., eds.) VCH Publishers, New York.
Edzes, H.T., Teerlink, T., van der Knaap, M.S., and Valk, J. (1992)Magn. Reson. Med. 26, 46–59.
Glonek, T., and Van Wazer, J.R. (1974)J. Magn. Reson 13, 390–391.
Greiner, J.V., Kopp, S.J., Sanders, D.R., and Glonek, T. (1981)Invest. Ophthalmol. Visual Sci. 21, 700–713.
Barany, M., and Glonek, T. (1982)Meth. Enzymol. 85B, 624–676.
Capuani, G., Aureli, T., Miccheli, A., Di Cocco, M.E., Ramacci, M.T., and Delfini, M. (1992)Lipids 27, 389–391.
Brenton, D.P., Garrod, P.J., Krywawych, S., Reynolds, E.O., Bachelard, H.S., Cox, D.W., and Morris, P.G. (1985)Lancet 1, 115.
Cerdan, S., Harihara Subramanian, V., Hilberman, M., Core, J., Egan, J., Chance, B., and Williamson, J.R. (1986)Magn. Reson. Med. 3, 432–439.
Burt, C.T., Cohen, S.M., and Barany, M. (1979)Annu. Rev. Biophys. Bioeng. 8, 1–25.
Coleman, A., and Gadian, D.G. (1976)Eur. J. Biochem. 61, 387–396.
Glonek, T., Henderson, T.O., Kruski, A.W., and Scanu, A.M. (1974)Biochim. Biophys. Acta 348, 155–161.
Horrocks, L.A., and Sharma, M. (1982) inPhospholipids (Hawthorne, J.N., and Ansell, G.B., eds.) pp. 71–72, Elsevier Biomedical Press, Amsterdam.
Albert, D.H., and Anderson, C.E. (1977)Lipids 12, 188–192.
Ronen, S.M., and Degani, H. (1992)Magn. Reson. Med. 25, 384–389.
Steen, R.G. (1989)Cancer Res. 49, 4075–4085.
Sachedina, S., Greiner, J.V., and Glonek, T. (1991)Invest. Ophthalmol. Visual Sci. 32, 625–632.
Glonek, T., Greiner, J.V., and Lass, J.H. (1990) inNMR: Principles and Applications to Biomedical Research (Pettegrew, J.W., ed.) pp. 157–203, Springer-Verlag, New York.
Meneses, P., Greiner, J.V., and Glonek, T. (1990)Exp. Eye Res. 50, 235–240.
Merchant, T.E., Lass, J.H., Roat, M.I., Skelnik, D.L., and Glonek, T. (1990)Curr. Eye Res. 9, 1167–1176.
Merchant, T.E., Lass, J.H., Meneses, P., Greiner, J.V., and Glonek, T. (1991)Invest. Ophthalmol. Visual Sci. 32, 549–555.
Merchant, T.E., Kasimos, J.N., de Graaf, P.W., Minsky, B.D., Gierke, L.W., and Glonek, T. (1991)Int. J. Colorect. Dis. 6, 121–126.
Merchant, T.E., Meneses, P., Gierke, L.W., Den Otter, W., and Glonek, T. (1991)Br. J. Cancer 63, 693–698.
Merchant, T.E., de Graaf, P.W., Minsky, B.D., Obertop, H., and Glonek, T. (1993)NMR Biomed. 6, 187–193.
Author information
Authors and Affiliations
About this article
Cite this article
Seijo, L., Merchant, T.E., van der Ven, L.T.M. et al. Meningioma phospholipid profiles measured by31P nuclear magnetic resonance spectroscopy. Lipids 29, 359–364 (1994). https://doi.org/10.1007/BF02537190
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02537190